KPV (Lysine–Proline–Valine) is a naturally occurring tripeptide corresponding to the C-terminal sequence of alpha-melanocyte-stimulating hormone (α-MSH). It has attracted research interest primarily for its potential involvement in inflammatory signalling, intestinal inflammation, immune responses and epithelial tissue protection.

Unlike many larger research peptides, KPV consists of only three amino acids:

Lysine – Proline – Valine (Lys-Pro-Val)

Key Research Areas

Inflammation Research
KPV is particularly well known for its anti-inflammatory activity in experimental models. Cell studies have shown inhibition of NF-κB and MAP kinase signalling, accompanied by reductions in pro-inflammatory cytokine secretion.

Gut & Intestinal Research
One of the most extensively investigated areas for KPV is intestinal inflammation. Experimental studies have evaluated KPV in DSS- and TNBS-induced models of colitis, where researchers observed reductions in inflammatory markers and tissue inflammation.

PepT1 Transport Pathway
KPV can be transported into intestinal epithelial and immune cells through the PepT1 peptide transporter. PepT1 expression can increase in the colon during intestinal inflammation, making this pathway particularly interesting for targeted gastrointestinal research.

NF-κB Signalling
NF-κB is an important regulator of inflammatory gene expression. Laboratory research has demonstrated that KPV can suppress activation of NF-κB and subsequently reduce secretion of inflammatory mediators.

Mucosal & Intestinal Barrier Research
KPV has also been incorporated into experimental nanoparticle and hydrogel delivery systems designed to target inflamed intestinal tissue. In mouse models, KPV-containing formulations have been investigated for their effects on mucosal healing and inflammatory responses.

Skin & Keratinocyte Research
KPV research is not limited to the gastrointestinal tract. Recent laboratory research using human keratinocytes found that KPV influenced oxidative stress, inflammatory signalling and cellular responses to particulate-matter exposure, including effects involving MAPK and NF-κB pathways.